General
Preferred name
Bekanamycin
Synonyms
BEKANAMYCIN SULFATE ()
KANAMYCIN B ()
Aminodeoxykanamycin ()
Bekanamicina ()
Nebramycin v ()
Bekanamycine ()
NK-1006 ()
NK 1006 ()
P&D ID
PD012022
CAS
4696-76-8
Tags
available
drug
natural product
Drug indication
Discovery agent
osteomyelitis
Drug Status
approved
experimental
investigational
Max Phase
3.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Bekanamycin (also known as kanamycin B) is one of the fermentation congeners produced by Streptomyces kanamyceticus . It has activity against Gram-positive and Gram-negative bacteria and belongs to the aminoglycoside class of antibacterial compounds. (GtoPdb)
PRICE 29
DESCRIPTION Bekanamycin (Kanamycin B) is an aminoglycoside antibiotic. (TargetMol Bioactive Compound Library)
Compound Sets
13
AdooQ Bioactive Compound Library
A18158
Cayman Chemical Bioactives
34561
ChEMBL Drugs
CHEMBL176
Drug Repurposing Hub
DrugBank
DB13673
DrugCentral
1520
DrugCentral Approved Drugs
1520
DrugMAP
DM79E2K
Guide to Pharmacology
12182
MedChem Express Bioactive Compound Library
HY-B1174
Selleckchem Bioactive Compound Library
bekanamycin
TargetMol Bioactive Compound Library
T8118
The Spectrum Collection
External IDs
42
Properties
(calculated by RDKit )
Molecular Weight
483.25
Hydrogen Bond Acceptors
15
Hydrogen Bond Donors
11
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
0
cLogP
-7.33
TPSA
288.4
Fraction CSP3
1.0
Chiral centers
15.0
Largest ring
6.0
QED
0.17
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
antibiotic
Bacterial
Indication
gram-negative bacterial infections
MOA
bacterial 30S ribosomal subunit inhibitor
Pathway
Microbiology/virology
Anti-infection
Source data